Try our beta test site
1 study found for:    NCT01683188
Show Display Options
Rank Status Study
1 Terminated HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
Condition: Metastatic Melanoma
Intervention: Drug: vemurafenib + HD IL-2

Study has passed its completion date and status has not been verified in more than two years.